EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, GNI Group's enterprise value is 円102,198 Mil.
GNI Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円26,011 Mil. Therefore, GNI Group's EV-to-Revenue for today is 3.93.
The historical rank and industry rank for GNI Group's EV-to-Revenue or its related term are showing as below:
TSE:2160'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.98 Med: 12.5 Max: 445.66
Current: 3.93
During the past 13 years, the highest EV-to-Revenue of GNI Group was 445.66. The lowest was 1.98. And the median was 12.50.
TSE:2160's EV-to-Revenue is ranked better than 67.5% of 1034
companies
in the Biotechnology industry
Industry Median: 8.18
vs TSE:2160: 3.93
As of today (2024-05-06), GNI Group's stock price is 円2441.00.
GNI Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円533.49. Therefore, GNI Group's PS Ratio for today is 4.58.
GNI Group EV-to-Revenue Historical Data
The historical data trend for GNI Group's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of GNI Group's EV-to-Revenue
For the Biotechnology subindustry, GNI Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GNI Group's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GNI Group's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where GNI Group's EV-to-Revenue falls into.
GNI Group's current Enterprise Value is 円102,198 Mil.
GNI Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円26,011 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNI Group's share price for today is 円2441.00.
GNI Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円533.49.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNI Group EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of GNI Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:2160 has been successfully added to your 